Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching hundreds of dollars per prescription. The poll found that about half of Americans ...

The drugs selected to undergo negotiations are: Ozempic ... (Currently, Medicare is barred from covering the drugs for weight loss.) “Driving a hard bargain at the negotiating table could ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...

The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and Wegovy, medications costing the massive government health program ...